BMRN News
BMRN
$58.51
+$1.02(+1.77%)
48
Overall
65
Value
27
Tech
52
Quality
Market Cap
$11.33B
Volume
2.23M
52W Range
-- - --
Target Price
$90.41
BMRN news: the latest BMRN headlines, press releases and market updates, newest first.
Latest BMRN News
- Robert W. Baird Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- 3 Healthcare Stocks with Strong Buy Ratings and Double-Digit UpsideSukanya Varma · Oct 21, 2026
- Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and MoonLake Immunotherapeutics (MLTX)TipRanks Newsroom · Oct 16, 2026
- BioMarin Pharmaceutical (BMRN) Initiated with a Buy at UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- RBC Capital Keeps Their Hold Rating on BioMarin Pharmaceutical (BMRN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- BioMarin’s Palynziq Desensitization Study Signals Effort to Protect Long‑Term PKU RevenueTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $58.51 | +1.8% | 2.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |